The kratom regulatory landscape in the United States is shifting... sometimes quickly, sometimes chaotically. In the past year alone, one state reversed a kratom ban, another rolled out new labeling requirements overnight, and a federal consumer protection framework moved closer to reality than it has in years.
As a brand that has been operating in this space for over 12 years, we've lived through every wave of this. Here's an honest breakdown of where things stand, what it means for you as a consumer, and why smart regulation, not prohibition, is the path that actually works.
Florida's 7-OH PPM Requirement: A Compliance Story
Florida recently enacted a requirement that kratom products sold in-state must display 7-hydroxymitragynine (7-OH) parts per million (PPM) data directly on product packaging.
NuWave Botanicals has never operated in the synthetic kratom space. We don't carry products with synthetic alkaloid derivatives, and our product line has always been built around naturally-occurring alkaloid profiles. But even for a brand like ours — fully natural, fully tested — the Florida ruling created a genuine operational emergency.
Our existing lab reports documented alkaloid content, but the PPM indicator as specifically defined by Florida's new requirement wasn't on them. That meant every product we ship to Florida customers needed to be retested, rushed, re-labeled with temporary stickers, and overnighted to affected customers. The retesting alone cost us roughly $4,000–$5,000 for a same-product rush run.
Was it frustrating? Absolutely. Was it the right call for the state to make? Probably because it targets something real. The distinction between naturally-occurring 7-OH and synthetically elevated 7-OH concentrations is exactly the line regulators need to be drawing. Florida drew it, and every credible brand complied.
What we've done since: We've updated our standard operating procedures so all future packaging automatically includes PPM data. One emergency labeling sprint is enough.
Rhode Island's Reversal: What Happens When a Legislator Actually Investigates
Rhode Island was one of the states that banned kratom in part because legislators believed it was a synthetic product. That ban has now been reversed, and the story behind the reversal is worth knowing.
Senator Brian Patrick Kennedy was central to the turnaround. Through outreach from the American Kratom Association, he was invited to visit Borneo specifically the farms and villages where kratom is cultivated. He met with farmers, village chiefs, and representatives from Indonesian regulatory and agricultural agencies. He visited laboratories that test kratom destined for export to the United States.
We were fortunate enough to assist Senator Kennedy on that trip, alongside Senator Kurt Bramble from Utah. What Kennedy brought back wasn't just a policy position, it was direct knowledge. He returned to Rhode Island and was able to articulate the difference between natural kratom, which has been part of Southeast Asian culture for hundreds of years, and the synthetic isolates that have been driving the dangerous headlines. That distinction, clearly communicated, backed by firsthand observation — was what moved the legislature.
Rhode Island's reversal is a model. It shows that when legislators take the time to actually investigate, they consistently reach the same conclusion: natural kratom and synthetic kratom derivatives are not the same thing, and policy should reflect that.
Connecticut vs. South Carolina: Two Approaches, One Lesson
Not every state has had a Rhode Island outcome. Connecticut banned kratom. South Carolina moved toward a regulated framework. The difference, in most cases, isn't science; it's bandwidth and political will.
Some legislators default to prohibition because it requires less work. A ban is a single vote. A regulatory framework requires drafting standards, engaging with industry and health experts, and committing to ongoing oversight. Small counties and local jurisdictions especially struggle here. They often lack the staff to research an industry they've never encountered.
Senator Bramble's work in Utah produced one of the early templates for smart kratom regulation: a consumer protection framework requiring products to be lab-tested, properly labeled, and free of synthetic adulterants. That template has been refined over time as the science has developed, and it's now being adapted for use in other states through the combined efforts of the American Kratom Association, the Global Kratom Coalition, and Botanical Health and Wellness.
The model works. It gives local legislators cover — they don't have to invent a regulatory approach from scratch. And it keeps kratom legal while holding manufacturers accountable for exactly the things consumers deserve accountability on: testing, labeling, purity.
The Federal KCPA: Closer Than It's Ever Been
The piece of the regulatory picture that carries the most long-term weight is the potential for a federal Kratom Consumer Protection Act (KCPA). A federal framework would give local legislators the clearest possible signal that natural kratom is a recognized botanical category with established standards and not a gray-market unknown.
The foundation for that signal already exists at the federal level. At a press conference late last year, representatives from HHS and the FDA both acknowledged that kratom has been used safely for hundreds of years in Southeast Asia, while making clear that enforcement attention is on synthetic derivatives being sold as kratom and not on the natural product itself.
That's meaningful. It means the federal agencies most relevant to kratom regulation are already drawing the same line that industry, researchers, and informed legislators have been drawing: natural is different from synthetic, and they should be regulated differently.
Whether federal legislation follows that signal is still an open question. But the advocacy groundwork, including direct education of senators and members of Congress, is actively underway.
What This Means If You're a Kratom Consumer
The regulatory environment is not static, and it can affect where products can be shipped and what information appears on packaging. A few things worth knowing:
Check your local regulations. Kratom's legal status varies by state and county, and the list of restrictions changes. The American Kratom Association maintains an up-to-date tracker at americankratom.org.
Lab testing is non-negotiable. Every credible brand, NuWave included, should be testing every batch independently and making certificates of analysis accessible. If a brand can't tell you what's in its product, that tells you something.
Natural vs. synthetic matters. The products driving negative headlines are, in most documented cases, synthetic derivatives, not traditional whole-leaf or standard extract kratom. These are distinct product categories, and it's worth understanding the difference before making any purchasing decision.
We comply with all applicable state and local laws. Orders to restricted areas are not fulfilled.